Quest Diagnostics to acquire Solstas Lab Partners for $570M Quest Diagnostics announced that it has entered into a definitive agreement under which Quest will acquire Solstas Lab Partners Group and its subsidiaries for a total transaction value of approximately $570M. Quest Diagnostics expects the transaction to add approximately 5% in annualized revenues, about 1% of which will be from professional lab services, and be modestly accretive to adjusted earnings per share in 2014. The company expects to complete the acquisition in the first half of 2014, subject to the satisfaction of customary closing conditions.
News For DGX From The Last 14 Days
Check below for free stories on DGX the last two weeks.